Home Archive
Archive
2023 Volume 44 Issue 10  Published: 2023-10-10
    Topic
  • Yanan ZHANG , Siriguleng , Hongxin YANG , Xiaobin GUO
    doi: 10.13683/j.wph.2023.10.001

    The deterioration of chronic heart failure (CHF) not only reduces the quality of life of patients, increases the risk of hospitalization and death, but also imposes a heavy burden on healthcare resources. In order to better manage CHF, the Heart Failure Association of the European Society of Cardiology has developed a new clinical consensus statement in 2023, updating the definition, clinical characteristics, management, and prevention of CHF deterioration. The consensus highlights the importance of diuretics, and intravenous, oral or combined diuretics should be selected depending on the severity of the patient. It also emphasizes the importance of early and rapid administration of guideline recommended medical therapies to prevent first deterioration and repeated exacerbations of heart failure. In order to relieve the medical pressure and meet the needs of patients for timely treatment, it is recommended to carry out hierarchical diagnosis and treatment for patients, mild to moderate patients in emergency or outpatient treatment, severe patients need to choose hospital treatment. This article provided a brief interpretation of the relevant content in order to provide reference for the clinical management of CHF.

  • Topic
  • Lixin ZHANG , Yongli LIANG , Siriguleng , Li ZHANG , Yanan ZHANG , Wudan , Hongxin YANG
    doi: 10.13683/j.wph.2023.10.002

    In 2022, the American College of Chest Physicians (ACCP) released the guidelines for the perioperative management of antithrombotic therapy. The guidelines mainly put forward antithrombotic recommendations for four clinical situations. Patients receiving vitamin K antagonists, heparin bridging, direct oral anticoagulants, antiplatelet drugs requiring surgery or invasive procedures, and perioperative laboratory testing were advised. This article compared with previous versions of the ACCP guidelines for perioperative antithrombotic therapy, and made a comprehensive interpretation of the guidelines combined with Shanghai Expert Consensus On Perioperative Management of Antithrombotic Patients Accepting Non-Cardiac Surgery (2021 Edition) and Chinese Guidelines for the Prevention and Treatment of Thrombotic Diseases, in order to provide references for the clinical application of antithrombotic drugs in perioperative period.

  • Topic
  • Zhaotang GONG , Wudan , Wurihan , Lixin ZHANG , Yanan ZHANG , Siriguleng
    doi: 10.13683/j.wph.2023.10.003

    Antibacterial drug resistance is a severe challenge for the treatment of bacterial infectious diseases worldwide, especially in the treatment of ultra broad extended-spectrum β-lactamase-producing Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae and drug-resistant Pseudomonas aeruginosa infected. In 2023, the Infectious Diseases Society of America provided guidance on the treatment of the three drug-resistant bacterial infections mentioned above based on updated evidence-based evidence. Based on the guidance and recommendations in domestic guidelines, this article reviewed the treatment for the three drug-resistant bacterial infections mentioned above, in order to provide clinical reference for the control and treatment of related diseases in China.

  • Article
  • Xiaoqiang NAN , Yanli WANG , Xiaofan JIANG , Peng LEI , Juane LI
    doi: 10.13683/j.wph.2023.10.004
    Objective

    To systematically evaluate the pharmacological effects and molecular mechanisms of Danlou tablets with comprehensive pharmacological strategies, and to provide a theoretical basis for the treatment of diabetic cardiomyopathy (DCM).

    Methods

    The chemical constituents and targets of Danlou tablets were discovered from the platform of pharmacology analysis of traditional Chinese medicine system, and the interaction network of "component-target" was established. All the targets of DCM were screened through the database, the relationship diagram of "component-disease target" was constructed. The core targets were screened, and the gene ontology analysis and the related pathway enrichment were performed on the core targets. The DCM rat model was treated with Danlou tablets to verify the predicted important signaling pathways.

    Results

    A total of 190 compound nodes and 275 target nodes were screened from 10 important formulations of Danlou tablet. A total of 19 targets related to DCM were screened from Danlou tablet, and 103 target related pathways had role in DCM. In vivo, Danlou tablet reduced the expression of fibrosis-related factor messenger RNA in myocardium of DCM rats and inhibited the expression of receptor for advanced glycation end products (RAGE)/nuclear factor (NF)-κB/nucleotide-binding oligomerization domain-like receptor protein (NLRP)3 pathway-related proteins RAGE and NLRP3, and phosphorylation of NF-κB (p65) protein.

    Conclusion

    Danlou tablets can inhibit myocardial fibrosis in DCM rats by blocking the activation of RAGE/NF-κB/NLRP3 signaling pathway, and then inhibiting the progression of the disease.

  • Article
  • Huifang ZHAO , Xiaopeng ZHANG , Zhijian WU , Nan WANG
    doi: 10.13683/j.wph.2023.10.005
    Objective

    To explore the effect of Xuanfei Tongluo Pingchuan decoction combined with probiotics in the treatment of bronchial asthma.

    Methods

    A total of 100 patients with bronchial asthma who were hospitalized in department of geriatric, Tangshan Fengnan District Hospital from October 2018 to October 2021 were selected and randomly divided into control group (probiotics) and experimental group (probiotics+Xuanfei Tongluo Pingchuan decoction), and 50 cases in each group. The clinical efficacy, recurrence, serum levels of gastrointestinal hormones, inflammatory factors, lung function and adverse reactions of the two groups were compared.

    Results

    The curative effect of the experimental group was obviously better than that of the control group (P<0.05). The 6-month recurrence rate of asthma and the number of patients with more than 2 acute attacks in the experimental group were significantly lower than those in the control group (P<0.05). After treatment, the levels of gastrin (GAS) in the two groups increased, and the levels of eosinophil (EOS), immunoglobulin E (IgE), C-reactive protein (CRP), tumor necrosis factor-α(TNF-α) and interleukin-6 (IL-6) decreased, and the levels of GAS in the experimental group was obviously higher than that in the control group, and the levels of EOS, IgE, CRP, TNF-α, and IL-6 were obviously lower than those in the control group (P<0.05). After treatment, forced expiratory volume in first second (FEV1), peak expiratory flow rate and FEV1/forced vital capacity ratio in the two groups increased, and the experimental group were obviously higher than those in the control group (P<0.05).

    Conclusion

    Xuanfei Tongluo Pingchuan decoction combined with probiotics can significantly improve the clinical efficacy of bronchial asthma patients, reduce asthma recurrence, improve gastrointestinal hormone levels and inflammatory reactions, enhance lung function, and have good safety.

  • Article
  • Zheng ZHOU , Guangming WANG , Youli LIU
    doi: 10.13683/j.wph.2023.10.006
    Objective

    To compare and analyze the effect of ursodeoxycholic acid combined with biliary stent drainage and biliary stent drainage alone in the treatment of biliary stricture.

    Methods

    Patients with biliary stricture who treated by endoscopic retrograde cholangiopancreatography (ERCP) in our hospital were collected from June 2019 to June 2021. The patients were divided into experimental group (ursodeoxycholic acid combined with biliary stent, 158 cases) and control group (biliary stent, 162 cases). The levels of total bilirubin (TBil) and alanine transaminase (ALT) before and after ERCP were analyzed. The complications were analyzed and the recurrence of biliary stricture was followed up for 6 months after ERCP.

    Results

    After treatment, the levels of TBil and ALT in the two groups were significantly lower than those before treatment (P<0.05). There was no significant difference in the incidence of complications between the two groups (P>0.05). After 6 months of follow-up, the recurrence rate of biliary stricture in the control group was higher, and the difference was statistically significant (P<0.05).

    Conclusion

    Both two groups can reduce jaundice, and ursodeoxycholic acid combined with biliary stent has a lower recurrence rate in the treatment of biliary stricture.

  • Article
  • Liu WANG , Gangzhi ZHU , Shengnan HAN , Hui PENG , Mei TONG , Lang XU , Xiaofei KANG , Tianqin ZHAO , Xiaoai HE , Hongdan WANG
    doi: 10.13683/j.wph.2023.10.007
    Objective

    To evaluate the bioequivalence, skin adhesion, irritation and safety of test preparation and reference preparation of 5% lidocaine gel patch on the skin of healthy volunteers under topical application condition.

    Methods

    A single-center, randomized, open-label, single-dose, two-cycle, two-sequence, two-crossover trial was designed. Thirty healthy subjects were randomly divided into RT group and TR group, subjects in RT group were treated with the reference preparation in the first cycle, and test preparation in the second cycle. Subjects in the TR group were treated with the test preparation in the first cycle, and reference preparation in the second cycle. The cleaning period was 3 days, 3 patches each time and continuous application for 12 h. The internal standard method and statistical method were used to calculate the main pharmacokinetic parameters, and the bioequivalence, adhesion and skin irritation of the two formulations were analyzed.

    Results

    The 90% confidence interval for the geometric mean ratio of plasma peak concentration of the test preparation and the reference preparation, the area under the blood concentration-time curve from 0 to the time t that can be accurately measured, and the area under the blood concentration-time curve from 0 to infinite time were all 80.00% to 125.00%. The adhesive force of the two formulations were completely consistent among all subjects at all time points. There was no statistically significant difference in skin irritation between the test preparation and the reference preparation (P>0.05).

    Conclusion

    The test preparation was bioequivalent to the reference preparation, with good safety, and the test preparation was not inferior to the reference preparation in adhesive force, and there was no difference in skin irritation.

  • Article
  • Menglu ZHANG , Xiaozhi BAI , Yuting ZHANG , Xiaojuan XIE
    doi: 10.13683/j.wph.2023.10.008
    Objective

    To analyze and compare the clinical efficacy of dexmedetomidine and remifentanil combined with propofol in painless induced abortion, and the effects of T cytokines, vital signs, and sexual hallucinations.

    Methods

    A total of 100 early pregnancy pregnant women who underwent painless induced abortion in our hospital from December 2018 to December 2020 were selected and divided into control group (dexmedetomidine+propofol) and study group (remifentanil+propofol) according to random number method, with 50 cases in each group. Anesthesia induction time, anesthesia effect, recovery time and discharge time of the two groups were observed. Serum interleukin (IL)-1β, IL-10, mean arterial pressure (MAP), heart rate (HR), pulse oxygen saturation (SpO2) changes and the incidence of sexual hallucinations were also observed.

    Results

    MAP and HR of the two groups after induction, during operation and after operation were lower than those before operation, and MAP and HR of the study group were higher than those of the control group at all periods (P<0.05). The difference of IL-1β and IL-10 levels in the study group before and after anesthesia was significantly lower than those in the control group (P<0.05). Compared with the control group, the incidence of sexual hallucinations in the study group was significantly lower after anesthesia (14% vs 36%). Anesthesia induction time [(122.08±21.49) s vs (82.92±11.41)s], recovery time [(3.58±1.05)min vs (3.08±1.03)min] and discharge time [(31.34±5.57)min vs (28.12±4.75)min] were significantly shortened. The total effective rate of anesthesia was significantly improved (80% vs 98%, P<0.05). Compared with the control group, serum IL-1β level was significantly decreased [(0.31±0.07)ng/ml vs (0.23±0.06)ng/ml] and serum IL-10 level was significantly increased [(36.41±12.34)pg/ml vs (44.96±11.02)pg/ml] after anesthesia.

    Conclusion

    The combination of remifentanil and propofol has better anesthetic effect than dexmedetomidine and propofol. The intraoperative vital signs are more stable, the inflammatory reaction is lighter, and the incidence of sexual hallucination is lower.

  • Article
  • Pengjie WAN , Meiyun LI , Yanxia WEI , Ji CHEN
    doi: 10.13683/j.wph.2023.10.009
    Objective

    To compare the difference of microbiota between lesions and non-lesions of elbow fossa in children with infantile atopic dermatitis (AD) and childhood AD, and to analyze the effect of emollient therapy on skin microbiota in mild pediatric AD patients.

    Methods

    By using self-control study, Illumina MiSeq sequencing platform was used to sequence the V3—V4 region of 16S ribosome DNA gene on the skin surface of AD children with and without skin lesions, and on the same skin lesion before and after treatment with emollient. The differences of microbiota between skin lesions and non-skin lesions and before and after treatment with emollient were compared.

    Results

    A total of 35 children with AD were included in the study. Compared with the normal skin without skin lesions, the abundance of staphylococci in AD elbow lesions was significantly increased and the α diversity of microbiota decreased significantly (P<0.05), and there was no significant difference between infantile AD and childhood AD. One month after treatment, Staphylococcus aureus changed from dominant microbiota to non-dominant microbiota.

    Conclusion

    Staphylococci colonization is the dominant bacteria in the skin lesions of infants with AD and childhood AD, and there is no difference in the composition of microbiota with age, and emollient treatment can change Staphylococcus aureus in skin lesions of mild childhood AD patients from dominant microbiota to non-dominant microbiota.

  • Article
  • Hui SUN , Haiyin WANG , Da HE , Xiaoxiao QIN , Xin LIU , Yichun GU , Chunlin JIN
    doi: 10.13683/j.wph.2023.10.010
    Objective

    To systematically evaluate the efficacy and safety of enteral nutrition preparations containing ω-3 polyunsaturated fatty acids or standard enteral nutrition preparations in patients with upper gastrointestinal cancer during the perioperative period, and to provide reference for clinical rational drug use.

    Methods

    Pubmed, EMbase, the Cochrane Library, CNKI, and Wanfang databases were searched for relevant literature. The search time limit was from the establishment of the database to June 1, 2022. Two researchers independently screened the literature, extracted data and assessed the risk of bias of the included studies. Stata16.0 software was used for meta-analysis.

    Results

    A total of 38 randomized controlled trials were included. The results of meta-analysis showed that compared with the standard enteral nutrition, enteral nutrition preparations containing ω-3 polyunsaturated fatty acids were more effective in reducing the infectious complications (relative risk=0.75, P<0.001), improving immune and inflammation-related indicators, albumin, and reducing the length of hospital stay (weighted mean differenc=-2.321, P<0.05).

    Conclusion

    Enteral nutrition preparations containing ω-3 polyunsaturated fatty acids have advantages in efficacy and safety in postoperative nutritional therapy for upper gastrointestinal cancer, and can be used as the preferred clinical drug. Limited by the quantity and quality of the included studies, the above conclusions need to be verified by more high-quality studies.

  • Article
  • Yanmin WANG , Xiaoming LI , Jingxian LIU , Song LIU , Xuejun GUO
    doi: 10.13683/j.wph.2023.10.011
  • Article
  • Wei PANG , Qinmin GE
    doi: 10.13683/j.wph.2023.10.012
  • Article
  • Shuili LV , Yanli ZHANG , Peng WANG , Yanbin SI
    doi: 10.13683/j.wph.2023.10.013
  • Review
  • Yunyan BI , Meng WU , Wen ZHANG , Lingjun KONG , Xianwei GONG
    doi: 10.13683/j.wph.2023.10.014

    In recent years, the review and approval of rare disease drugs in China has been accelerated, and the negotiation of access to the national medical insurance drug catalogue has been fully launched. Through comparative analysis of the national conversation catalogue over the years, it can be seen that from 2017 to 2022, the number of rare disease drugs included in medical insurance through national negotiations has increased from zero to 29 year by year, the time from listing to inclusion in medical insurance has been significantly shortened, and the accessibility has been significantly improved. The list of rare diseases drugs covered 16 rare disease, including 26 (89.6%) imported enterprise products and 3 (10.4%) domestic enterprise products. It reveals that although the number of rare disease drugs listed and medical insurance coverage in China have increased, the coverage of rare diseases is still small, and the research and innovation ability of domestic pharmaceutical enterprises is relatively weak. It is suggested that medical insurance, medical treatment and medicine should continue to play a synergistic role to provide sustainable impetus for the guarantee of rare disease drug use in China.

  • Review
  • Yanmei SU , Liping GU
    doi: 10.13683/j.wph.2023.10.015

    In recent years, the complex preparation of glucagon-like peptide-1 receptor agonist (GLP-1RA) and basal insulin has attracted much attention. It has significant efficacy and good safety in patients with type 2 diabetes mellitus, which can effectively control blood glucose level, reduce body mass gain, gastrointestinal adverse reactions and the risk of cardiovascular diseases, reduce the incidence of hypoglycemia and treatment costs, and improve patient compliance. This article reviewed the research progress of GLP-1RA and basic insulin compound preparation, to clarify its mechanism and efficacy, and provide certain reference for clinical practice.

  • Review
  • Xuetong WANG , Bilian KE
    doi: 10.13683/j.wph.2023.10.016

    Low vision (LV) seriously affected the daily life of patients. The diagnosis, treatment and rehabilitation of LV are of great significance. The LV rehabilitation program should be formulated after professional evaluation, the primary disease diagnosis and treatment should be standardized, and visual or non-visual rehabilitation means should be adopted to improve the quality of life of patients. In visual rehabilitation, new head-mounted display based on virtual reality and augmented display technology have developed rapidly in recent years, which can help LV patients improve visual function and quality of life. This article reviewed the research progress of diagnosis, treatment and rehabilitation of LV in order to provide clinical reference.

  • Review
  • Xiangjin GAO , Ruiping WANG
    doi: 10.13683/j.wph.2023.10.017

    Gestational diabetes mellitus (GDM) is a metabolic disorder during pregnancy. In recent years, the prevalence rate of GDM is high and rising rapidly. GDM can cause serious harm to both mother and infant, inducing macrosomia, fetal distress, fetal anomaly, etc. It can also cause type 2 diabetes mellitus and cardiovascular diseases in the mother. Physical exercise can prevent GDM and help GDM patients control blood glucose. This article summarized the effects of physical exercise in the prevention of GDM, focused on the effects of physical exercise on blood glucose control and pregnancy outcome in GDM patients, and summarized the common exercise methods, exercise time, frequency and intensity, so as to provide a basis for more research in related fields, promote the application of physical exercise in GDM, and thus provide certain protection for maternal and child health.

  • Review
  • Manman LI , Linyun ZHU , Tong WU , Haifeng ZHOU
    doi: 10.13683/j.wph.2023.10.018

    Bronchial asthma is one of the common chronic respiratory diseases in clinic. Western medicine mainly treats with glucocorticoids and bronchodilation drugs, but there are many adverse reactions, resulting in poor patient compliance and high recurrence rate. Traditional Chinese medicine (TCM) has certain advantages in the prevention and treatment of bronchial asthma, which can reduce the hormone dependence of patients, reduce the occurrence of adverse reactions, and reduce the number of recurrence. This article reviews the etiology and treatment, syndrome differentiation and clinical research progress of TCM in the prevention and treatment of bronchial asthma, in order to provide new ideas for the prevention and treatment of bronchial asthma.

  • Pharmacy administration
  • Wenyi RUAN , Meng ZHANG , Biao YU , Heping CAI , Xiaoling WANG , Zhigang ZHAO
    doi: 10.13683/j.wph.2023.10.019
    Objective

    To investigate the current situation of accessibility of essential medicines for children in China, to provide reference for the establishment of children's essential medicines list and to promote the accessibility of essential medicines for children in China.

    Methods

    By comparing the "Model List of Essential Medicines for Children" issued by WHO in 2021 and the "National Essential Medicines List" issued by China in 2018, the list of essential medicines for children was screened and a questionnaire was made. From March 3 to March 20, 2022, a survey on the accessibility of 124 essential medicines was conducted in 31 children's specialized hospitals and maternal and child health hospitals across the country in the form of questionnaires. The survey included drug availability, manufacturers, prices and usage in 2021.

    Results

    Among the 124 investigated drugs, 106 drugs were available and 18 drugs were unavailable. Among the available drugs, the average availability of chemical drugs, biological products and proprietary Chinese medicines was 40.51%, 35% and 27.6%, respectively. The median price ratio (MPR) of 12 primary drugs was 7.62, and the MPR of 46 generic drugs was 1.95. The MPR of 11 drugs with both primary and generic drugs were 8.35 and 1.43, respectively. The affordability analysis of 5 essential medicines for children with asthma, nephrotic syndrome and epilepsy showed that the drug cost of 1 treatment plan was lower than the national daily minimum wage, indicating that the affordability of the 5 drugs was well affordable. For the 9 essential medicines with both primary and generic drugs, 5 primary drugs were used more frequently than generic drugs, and the other 4 drugs were used less frequently than generic drugs.

    Conclusion

    Among the 124 essential medicines, the availability of chemical drugs, biological products and proprietary Chinese medicines was low. For the essential medicines commonly used in children for asthma, epilepsy and nephrotic syndrome, generic drugs have reasonable prices and good affordability. The price of the primary drug is basically reasonable, and the affordability is weaker than that of generic drugs. The frequency of use of the primary drug was slightly higher than that of the generic drug.

News